Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
JCSE 01 - Joint IASLC/CSCO/CAALC Session: Immunotherapy for Management of Lung Cancer: Ongoing Research from East and West
- 07:30 - 11:30
- 10/15/2017
- Location: F203 (Annex Hall)
- Type: Joint Session IASLC/CSCO/CAALC
- Track: Immunology and Immunotherapy
- Moderators:C. Bai, Fred R. Hirsch, Tony SK Mok, Yi-Long Wu
-
+
JCSE 01.28 - NGS Sequencing Based Liquid / Tissue Biopsy Identified Coexistence of HER2 Amplification and Mutation in Advanced NSCLC Patients
11:30 - 11:30 | Presenter: Rongrong Chen | Author(s): J. Zhao, G. Lin, L. Liu, L. Chen, X. Hu, X. Ai, Z. Fan, C. Xu, W. Wang, W. Zhuang, M. Fang, Y. Zhu, G. Chen, Y. Guan, L. Yang, X. Xia, X. Yi
- Abstract
Loading...
-
+
P1.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P1.07 - Immunology and Immunotherapy
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Immunology and Immunotherapy
-
+
- Abstract
Loading...
-
+
P1.14 - Radiotherapy
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Radiotherapy
-
+
- Abstract
Loading...
-
+
P2.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P2.03-034 - EGFR Exon 19 Deletion Is Associated with Favorable Overall Survival After First-Line Icotinib Therapy in Advanced NSCLC Patients
09:30 - 09:30 | Presenter: Xiaochun Zhang | Author(s): C. Zhang, H. Hou, X. Cheng, D. Gong, H. Liu, H. Yu, W. Zhu, J. Zhu, K. Liu, H. Lv, N. Zhou, J. Cong, D. Liu, L. Yang, M. Jiang, Y. Zhang, L. Chen, Y. Zhu
- Abstract
Loading...
-
+
P2.07 - Immunology and Immunotherapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Immunology and Immunotherapy
-
+
P2.07-062b - DNA Damage Repair Targeting Upregulates PD-L1 Level and Potentiates the Effect of PD-L1 Blockade in Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Triparna Sen | Author(s): L. Chen, B..L. Rodriguez, C.M. Gay, L. Li, Y. Yang, Y. Fan, B. Glisson, J. Wang, H. Piwnica-Worms, Julien Sage, John V Heymach, Don Lynn Gibbons, L.A. Byers
- Abstract
No abstract available for this presentation
-
+
P2.14 - Radiotherapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Radiotherapy
-
+
- Abstract
Loading...
-
+
P3.01 - Advanced NSCLC
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P3.01-087 - Impact Factor Analysis for Efficacy and Prognosis of Anlotinib in NSCLC as Third-Line Treatment: Data from Trial ALTER 0303
09:30 - 09:30 | Presenter: Kai Li | Author(s): J. Wang, Baohui Han, Y.Z. Zhao, Qiming Wang, L. Zhang, J. Shi, Z. Wang, J. He, Yuankai Shi, Ying Cheng, W. Chen, X. Wang, Y. Luo, K. Nan, F. Jin, J. Dong, B. Li, Y. Chen, J. Zhou, D. Wang, X. Zhou, Y. Yu, L. Chen, A. Liu, J. Huang, C. Huang, B. Cao, J. Chen, R. Ma, Z. Yu, C. Ding, H. Wang
- Abstract
Loading...
-
+
P3.04 - Clinical Design, Statistics and Clinical Trials
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Clinical Design, Statistics and Clinical Trials
-
+
P3.04-010 - Validation of a ctDNA Methylation Assay to Differentiate Benign and Malignant Pulmonary Nodules: A Chinese Nationwide Multi-Center Study
09:30 - 09:30 | Presenter: Wenhua Liang | Author(s): J. He, X. Zhi, F. Yu, C. Cheng, Z. Wang, K. Cai, G. Jiang, C. Chen, Q. Luo, L. Chen, J. Hu, L. Liu, X. Li, Q. Wu, S. Xu, J. Liu, Y. Yang, H. Tian, X. Cai, J. Fan, O.B.O. Chinese Clincal Trial Consortium (cctc)
- Abstract
Loading...
-
+
OA 10 - Liquid Biopsy for Genomic Alterations
- 11:00 - 12:30
- 10/18/2017
- Location: F201 + F202 (Annex Hall)
- Type: Oral
- Track: Advanced NSCLC
- Moderators:Adrian G. Sacher, Pasi A Jänne
-
+
OA 10.05 - Non-Invasive Molecular Profiling in NSCLC by Targeted and Whole Exome Analysis of Plasma cfDNA
11:45 - 11:55 | Presenter: Dana W.Y. Tsui | Author(s): M.L. Cheng, J.L. Yang, M. Shady, P. Ulz, E. Heitzer, N.D. Socci, V. Seshan, M. Offin, D. Stephens, A. Makhnin, N. Tandon, S. Datta, D.S. Selcuklu, K. Huberman, K. Vanness, E. Gedvilaite, A. Viale, Maria E Arcila, Marc Ladanyi, J.E. Chaft, Charles M Rudin, M.F. Berger, D.B. Solit, Bob T. Li
- Abstract
Loading... -
+
- Abstract
Loading...